Literature DB >> 29078517

Role of thoracoscopy, mediastinoscopy and laparoscopy in the diagnosis and staging of malignant pleural mesothelioma.

Ori Wald1, Shawn S Groth1, Bryan M Burt1, David J Sugarbaker1.   

Abstract

Malignant pleural mesothelioma (MPM) is an aggressive malignancy with dismal prognosis. Unfortunately, chemotherapy only marginally extends patient survival and palliative care often remains the sole therapeutic option. Nonetheless, for a selected group of patients that present with an early disease stage and an epithelioid histology, a personally tailored multimodality therapeutic (MMT) protocol comprising of cyto-reductive surgery and chemotherapy with or without radiation therapy may significantly prolong survival. Accurately selecting patients for this aggressive therapeutic approach is challenging and is based in part on optimal pre-surgical staging. Here we discuss the role of thoracoscopy, mediastinoscopy and laparoscopy in the diagnosis and staging of MPM patients prior to definite surgical resection.

Entities:  

Keywords:  Mesothelioma; mediastinoscopy laparoscopy; thoracoscopy

Year:  2016        PMID: 29078517      PMCID: PMC5637746          DOI: 10.21037/jovs.2016.07.12

Source DB:  PubMed          Journal:  J Vis Surg        ISSN: 2221-2965


  14 in total

1.  Extended surgical staging for potentially resectable malignant pleural mesothelioma.

Authors:  David C Rice; Jeremy J Erasmus; Craig W Stevens; Ara A Vaporciyan; Judy S Wu; Anne S Tsao; Garrett L Walsh; Stephen G Swisher; Wayne L Hofstetter; Nelson G Ordonez; W Roy Smythe
Journal:  Ann Thorac Surg       Date:  2005-12       Impact factor: 4.330

2.  Surgical assessment of malignant pleural mesothelioma: have we reached a critical stage?

Authors:  Apostolos Nakas; Edward Black; James Entwisle; Salli Muller; David A Waller
Journal:  Eur J Cardiothorac Surg       Date:  2010-02-06       Impact factor: 4.191

3.  Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.

Authors:  David J Sugarbaker; Ritu R Gill; Beow Y Yeap; Andrea S Wolf; Marcelo C DaSilva; Elizabeth H Baldini; Raphael Bueno; William G Richards
Journal:  J Thorac Cardiovasc Surg       Date:  2013-02-21       Impact factor: 5.209

4.  The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass.

Authors:  Valerie Rusch; Elizabeth H Baldini; Raphael Bueno; Marc De Perrot; Raja Flores; Seiki Hasegawa; Walter Klepetko; Lee Krug; Loïc Lang-Lazdunski; Harvey Pass; Walter Weder; David J Sugarbaker
Journal:  J Thorac Cardiovasc Surg       Date:  2013-02-14       Impact factor: 5.209

Review 5.  Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.

Authors:  Nico van Zandwijk; Christopher Clarke; Douglas Henderson; A William Musk; Kwun Fong; Anna Nowak; Robert Loneragan; Brian McCaughan; Michael Boyer; Malcolm Feigen; David Currow; Penelope Schofield; Beth Ivimey Nick Pavlakis; Jocelyn McLean; Henry Marshall; Steven Leong; Victoria Keena; Andrew Penman
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

6.  Survival after conservative (palliative) management of pleural malignant mesothelioma.

Authors:  N Merritt; C J Blewett; J D Miller; W F Bennett; J E Young; J D Urschel
Journal:  J Surg Oncol       Date:  2001-11       Impact factor: 3.454

7.  Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma.

Authors:  Daniel R Gomez; David S Hong; Pamela K Allen; James S Welsh; Reza J Mehran; Anne S Tsao; Zhongxing Liao; Stephen D Bilton; Ritsuko Komaki; David C Rice
Journal:  J Thorac Oncol       Date:  2013-02       Impact factor: 15.609

8.  Initial analysis of the international association for the study of lung cancer mesothelioma database.

Authors:  Valerie W Rusch; Dorothy Giroux; Catherine Kennedy; Enrico Ruffini; Ayten K Cangir; David Rice; Harvey Pass; Hisao Asamura; David Waller; John Edwards; Walter Weder; Hans Hoffmann; Jan P van Meerbeeck
Journal:  J Thorac Oncol       Date:  2012-11       Impact factor: 15.609

9.  Preoperative staging of mesothelioma by 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography fused imaging and mediastinoscopy compared to pathological findings after extrapleural pneumonectomy.

Authors:  Jens Benn Sørensen; Jesper Ravn; Annika Loft; Jørn Brenøe; Anne Kiil Berthelsen
Journal:  Eur J Cardiothorac Surg       Date:  2008-09-16       Impact factor: 4.191

10.  Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.

Authors:  Marc de Perrot; Ronald Feld; B C John Cho; Andrea Bezjak; Masaki Anraku; Ronald Burkes; Heidi Roberts; Ming S Tsao; Natasha Leighl; Shaf Keshavjee; Michael R Johnston
Journal:  J Clin Oncol       Date:  2009-02-17       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.